Mελέτη φάσης ΙΙΙ που φέρνει αντιμέτωπη την επικουρική χρήση του Sutent της Pfizer με το εικονικό φάρμακο σε ασθενείς με καρκίνο στα νεφρά
11 July 2016

 

Translarna Now Available for Duchenne in England
11 July 2016

The National Health Service (NHS) England and PCT Therapeutics have negotiated a managed access agreement (MAA) for Ataluren (Translarna) for ambulatory patients of the age of five years and olde

EU allows paediatric use of Shire’s Restive
8 July 2016

European regulators have approved the use of Shire's Restive in children with short bowel syndrome (SBS), a rare and potentially life-threatening gastrointestinal condition.

Europe expands use of Takeda’s Adcetris
7 July 2016

Takeda has received European Commission approval for the expanded use of Adcetris as a consolidation treatment in post-transplant Hodgkin lymphoma.

EU expands label of Amgen’s Kyprolis
5 July 2016

European regulators have cleared the use of Amgen's Kyprolis in combination with just dexamethasone to treat certain adults with multiple myeloma.

FDA Approves IND for BHV-4157
5 July 2016

Today, Biohaven Pharmaceuticals announced that the U.S.

FDA Approves Humira for Non-infectious Uveitis
2 July 2016

The FDA has approved Humira (adalimumab) for the treatment of non-infectious intermediate, posterior and panuveitis.

Phase 3 Ovarian Cancer Study Meets Primary Endpoint
30 June 2016


Tesaro Inc announced their Phase 3 ovarian cancer study achieved its primary endpoint of progression-free survival (PFS).